Literature DB >> 6646208

Placebo and naloxone can alter post-surgical pain by separate mechanisms.

R H Gracely, R Dubner, P J Wolskee, W R Deeter.   

Abstract

The discovery of an endogenous opioid-mediated analgesic system has led to the search for its physiological roles and how it might be activated in natural conditions. Environmental and surgical stress and certain forms of transcutaneous electrical stimulation or acupuncture appear to activate this system. Several studies also suggest that this opioid system mediates placebo analgesia. Placebo reduces post-surgical pain in comparison with no treatment, and this analgesia is apparently reversed by the opioid antagonist, naloxone. However, these studies did not indicate whether naloxone and placebo exert their effects by common or by separate mechanisms. By administering hidden infusions of naloxone (in subjects unaware that the medication was being given) separate from the administration of a placebo, we were able to assess the effects of these two treatments independently. We report here evidence that placebo analgesia can occur after blockade of opioid mechanisms by naloxone and that naloxone can produce hyperalgesia independent of the placebo effect. The combined action of these effects is sufficient to explain the reversal of placebo analgesia by naloxone.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6646208     DOI: 10.1038/306264a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  37 in total

1.  Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans.

Authors:  Irene Tracey
Journal:  Nat Med       Date:  2010-10-14       Impact factor: 53.440

Review 2.  Implications of placebo theory for clinical research and practice in pain management.

Authors:  C Peck; G Coleman
Journal:  Theor Med       Date:  1991-09

Review 3.  Placebo analgesia: friend or foe?

Authors:  Donald D Price; Roger B Fillingim; Michael E Robinson
Journal:  Curr Rheumatol Rep       Date:  2006-12       Impact factor: 4.592

4.  Placebo effects on human mu-opioid activity during pain.

Authors:  Tor D Wager; David J Scott; Jon-Kar Zubieta
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

Review 5.  Placebo effects: clinical aspects and neurobiology.

Authors:  Barry S Oken
Journal:  Brain       Date:  2008-06-21       Impact factor: 13.501

6.  Introduction to placebo effects in medicine: mechanisms and clinical implications.

Authors:  Karin Meissner; Niko Kohls; Luana Colloca
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

7.  Peak B endorphin concentration in cerebrospinal fluid: reduced in chronic pain patients and increased during the placebo response.

Authors:  J J Lipman; B E Miller; K S Mays; M N Miller; W C North; W L Byrne
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

8.  Endogenous monoamine analgesic systems: amitriptyline in painful diabetic neuropathy.

Authors:  M B Max
Journal:  Anesth Prog       Date:  1987-07

Review 9.  Anger expression and pain: an overview of findings and possible mechanisms.

Authors:  Stephen Bruehl; Ok Y Chung; John W Burns
Journal:  J Behav Med       Date:  2006-06-29

10.  Specifying the non-specific factors underlying opioid analgesia: expectancy, attention, and affect.

Authors:  Lauren Y Atlas; Joseph Wielgosz; Robert A Whittington; Tor D Wager
Journal:  Psychopharmacology (Berl)       Date:  2013-10-06       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.